Monosodium L-glutamate-induced obesity impaired the adrenal medullae activity

Neuroscience Research Communications

Volumn 28, Issue 1, 2001, Pages 49-58

  Martins, Andréia C P ^a   Borges, Heraldo E ^a   Garcia, Raul M G ^b   Carniatto, Sandra R ^a   Mathias, Paulo C F ^a  

^a STATE UNIVERSITY OF MARINGÁ   (Brazil)

^b FEDERAL UNIVERSITY OF JUIZ DE FORA   (Brazil)

Author keywords

Adrenal medulla; Catecholamines; Mice; MSG; Obesity; Secretion

Indexed keywords

CARBACHOL; CATECHOLAMINE; CHOLINESTERASE; GLUTAMATE SODIUM; POTASSIUM;

ADRENAL MEDULLA; ADRENERGIC SYSTEM; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CATECHOLAMINE RELEASE; CONTROLLED STUDY; HYPERPHAGIA; HYPOPHYSIS ADRENAL SYSTEM; HYPOTHALAMUS; MALE; MOUSE; NEUROTRANSMISSION; NONHUMAN; OBESITY;

EID: 0035119516     PISSN: 08936609     EISSN: None     Source Type: Journal    
DOI: 10.1002/1520-6769(200101/02)28:1<49::AID-NRC6>3.0.CO;2-L     Document Type: Article

References (47)

1. A low sympathoadrenal activity is associated with body weight gain and development of central adiposity in Pima Indian men
2. New insights into sympathetic regulation of glucose and fat metabolism
3. Diminished epinephrine excretion in genetically obese (ob/ob) mice and monosodium glutamate-treated rats
4. Decreased central and peripheral catecholaminergic activation in obese Zucker rats
5. Lipogenesis in situ in the genetically obese Zucker fatty rat (fa/fa): Role of hyperphagia and hyperinsulinaemia
6. Differences in lipogenesis in tissues of control and gold-thioglucose obese mice after an isocaloric meal
7. Brown adipose tissue in genetically obese (fa/fa) rats: Response to cold and diet
8. Reduced BAT function as a mechanism for obesity in the hypophagic, neuropeptide Y deficient monosodium glutamate-treated rat
9. Benidipine induces thermogenesis in brown adipose tissue by releasing endogenous noradrenaline: A possible mechanism for the antiobesity effect of calcium antagonists
10. Monosodium glutamate induced lesions of the arcuate nucleus. I. Endocrine deficiency and ultrastructure of the median eminence
11. Models of neuroendocrine regulation: Use of monosodium glutamate as an investigational tool
12. Divergent effects of acute and chronic monosodium L-glutamate treatment on the anterior and posterior parts of the arcuate nucleus
13. Reduced norepinephrine turnover in brown adipose tissue of pre-obese mice treated with monosodium-L-glutamate
14. Effects of cigarette smoke on norepinephrine turnover and thermogenesis in brown adipose tissue in MSG-induced obese mice
15. Sex-related alterations in hypothalamic tyrosine hydroxylase after neonatal monosodium glutamate treatment
16. Correlation between Lee index and carcass fat content in weanling and adult female rats with hypothalamic lesions
17. Glucose does not affect catecholamine stimulus-secretion coupling in rat adrenal medulla: Relationship to low changes in osmolarity and to insulin
18. A comparison of trihydroxyindole and HPLC/electrochemical methods for catecholamine measurement in adrenal chromaffin cells
19. A new and rapid colorimetric determination of acetylcholinesterase activity
20. Protein measurement with the folin phenol reagent
21. The effect of adipose cell size on the measurement of GLUT 4 in white adipose tissue of obese mice
22. Neonatal treatment with monosodium glutamate: Effects of prolonged growth hormone (GH)-releasing hormone deficiency on pulsatile GH secretion and growth in female rats
23. Studies of gene expression in liver of insulin-like growth factor (IGF)- I, IGF binding protein-3 and growth hormone (GH) receptor/GH binding protein in rats treated neonatally with monosodium glutamate
24. Acute hyperinsulinemia and its reversal by vagotomy after lesions of the ventromedial hypothalamus in anesthetized rats
25. Overfeeding, autonomic regulation and metabolic consequences
26. Plasma lipoproteins of monosodium glutamate-induced obese rats
27. Monosodium L-glutamate lesions reduce susceptibility to hypoglycemic feeding and convulsions
28. The hypothalamus, and diabetes: Insights into the central control of metabolism
29. Attenuation of leptin-mediated effects by monosodium glutamate-induced arcuate nucleus damage
30. Development of hypothalamic obesity in growing rats
31. The MONA LISA hypothesis in the time of leptin
32. Morphological and cell proliferative study on the growth of visceral organs in monosodium L-glutamate-treated obese mice
33. Neonatal treatment with monosodium glutamate increases plasma corticosterone in the rat
34. Components of hypothalamic obesity: Bipiperidyl-mustard lesions add hyperphagia to monosodium glutamate-induced hyperinsulinemia
35. Ventromedial hypothalamic lesions and the mobilization of fatty acids
36. Exercise-induced sympathetic FFA mobilization in VMH-lesioned rats is normalized by fasting
37. Sympathoadrenal function in genetically obese Zucker rats
38. Hypothalamic obesity, brown adipose tissue, and sympathoadrenal activity in rats
39. Catecholamine synthesizing enzymes in various brain regions of the genetically obese Zucker rat
40. Nicotinic cholinergic regulation of tyrosine hydroxylase gene expression and catecholamine synthesis in isolated bovine adrenal chromaffin cells
41. Calcium mobilization and catecholamine secretion in adrenal chromaffin cells. A Quin-2 fluorescence study
42. Electrical activity in chromaffin cells of intact mouse adrenal gland
43. ChE-stained horizontal sections of the rat brain in stereotaxic coordinates
44. Chronic imipramine treatment-induced changes in acetylcholinesterase (EC 3.1.1.7) activity in discrete rat brain regions
45. Acetylcholinesterase staining and choline acetyltransferase activity in the young adult rat spleen: Lack of evidence for cholinergic innervation
46. The innervation of the mammalian adrenal gland
47. Vesicular acetylcholine transporter (VAChT) protein: A novel and unique marker for cholinergic neurons in the central and peripheral nervous systems